Roswell Park Cancer Institute is committed to the support of all cancer patients from Canada and the United States.

If you are visiting this site, and your healthcare is based in Canada, please know that our physicians and support staff will work with your Canadian care team if it is determined that you would benefit from receiving some of your care at the Roswell Park Cancer Institute.

Roswell Park is a leader in delivering the latest and most promising therapies. For example, we were among the first institutions to offer Erbitux for the treatment of colon cancer as part of a clinical trial, before its approval by the U.S. Food and Drug Administration. Our physicians not only laid the groundwork for its current use, but as a member of the elite National Comprehensive Cancer Network (NCCN), we also established the guidelines for its use.

If you would like to receive more information, please call 1-877-ASK-RPCI or email askrpci@roswellpark.org.  Please browse our site for more information.